Table 4: Effect of KIR-HLA ligand matches/mismatches on graft survival among CMV infected renal transplant cases.

KIR HLA CMV Non-CMV
KIR-HLA ligand match
Chi-Square (X) p-value Mean Survival+SE (in months) 95%CI Mean Survival+SE (in months) 95%CI
KIR2DL2 HLA-C1 1.21 0.211 32.00 7.69 19.42-41.31 51.22 1.12 46.89-59.91
KIR2DL3 HLA-C1 0.23 0.062 29.00 5.23 21.21-42.52 49.73 1.98 42.63-57.32
KIR2DS2 HLA-C1 0.78 0.321 38.50 6.98 24.81-52.18 65.71 2.25 61.28-70.14
KIR2DS3 HLA-C1 2.17 0.140 37.66 8.61 20.77-54.55 65.83 2.25 61.42-70.24
KIR2DL1 HLA-C2 3.45 0.013* 36.41 7.59 36.41 7.59 55.79 2.21 51.45-60.14
KIR2DS1 HLA-C2 0.32 0.005* 40.16 8.75 23.00-57.33 72.78 2.42 68.03-77.53
KIR3DL1 HLA-Bw4 3.23 0.032* 36.00 7.82 20.66-51.33 54.12 2.09 50.01-58.23
KIR3DS1 HLA-Bw4 1.73 0.201 36.41 7.84 21.04-51.78 59.80 2.32 55.24-64.36


*= p< 0.05 & statistically significant.